Elizabeth M. Jaffee, MD • SITC 2020 Keynote

SITC 2020 Keynote Speaker 

Jaffee_Elizabeth_2020.jpgSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Keynote Address | Thursday Nov. 12 at 9 a.m. EST
Turning Immunologically Quiescent Tumors into Immune Responsive cancers 

Dr. Jaffee is an internationally recognized expert in cancer immunology and pancreatic cancer. She is Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Co-Director of the Skip Viragh Pancreatic Cancer Center and Associate Director of the Bloomberg Kimmel Institute for Cancer Immunotherapy. Her research focus is on developing novel immunotherapies for the treatment and prevention of pancreatic cancer. Dr. Jaffee is a Past President of the American Association for Cancer Research (AACR). She has served on a number of committees at the National Cancer Institute including co-chair of the Blue Ribbon Panel that provided scientific advice to Vice President Biden’s Moonshot Initiative. She currently serves as chair of the National Cancer Advisory Board and Chief Medical Advisor to the Lustgarten Foundation for Pancreatic Cancer Research. She is the inaugural Director of the new Convergence Institute at Johns Hopkins.